Wordt geladen...
Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma
The clinical management of relapsed/refractory multiple myeloma and the correct choice of the most suitable therapy in heavily pretreated and fragile patients are tough clinical issues for clinicians. In advanced phases of disease, the choice of available therapies becomes very poor, and the retreat...
Bewaard in:
| Gepubliceerd in: | Case Rep Hematol |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi Publishing Corporation
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5102715/ https://ncbi.nlm.nih.gov/pubmed/27867671 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6745286 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|